L-arginine inhibits smooth muscle cell proliferation of vein graft intimal thickness in hypercholesterolemic rabbits

Cardiovascular Research

Volumn 36, Issue 3, 1997, Pages 429-436

  Okazaki, Jin ^a   Komori, Kimihiro ^a   Kawasaki, Katsumi ^a   Eguchi, Daihiko ^a   Ishida, Masaru ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Hypercholesterolemia; L arginine; Nitric oxide; Vein graft

Indexed keywords

ARGININE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CHOLESTEROL DIET; CONTROLLED STUDY; GRAFT FAILURE; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; INTIMA; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; VEIN GRAFT;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; ARGININE; BROMODEOXYURIDINE; CELL DIVISION; CITRULLINE; GRAFT REJECTION; HYPERCHOLESTEROLEMIA; JUGULAR VEINS; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; OMEGA-N-METHYLARGININE; RABBITS; TUNICA INTIMA;

EID: 0031470259     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00188-0     Document Type: Article

References (44)

1. Szilagyi D.E., Hageman J.H., Smith R.F., Elliott J.P., Brown F., Dietz P. Autogenous vein grafting femoropopliteal atherosclerosis. Surgery. 86:1979;836-851.
2. Bernhard VM. Bypass to popliteal and infrapopliteal arteries. In: Rutherford RB, editor. Vascular Surgery, 3rd edn. Philadelphia: Saunders, 1989;692-704.
3. Gunstensen J., Smith R.C., El-Maraghi J.J., Belbeck L. Intimal hyperplasia in autogenous veins used for arterial replacement. Can J Surg. 25:1982;158-161.
4. Karayannacos P.E., Hostetler J.R., Bond M.G., Kakos G.S., Williams R.A., Kilman J.W., Vasco J.S. Late failure in vein grafts: mediating factors in subendothelial fibromuscular hyperplasia. Ann Surg. 187:1978;183-188.
5. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
6. Johnston G., Tsao P.S., Malloy D., Leffer A.M. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther. 252:1990;35-41.
7. Kubes P., Suzuki M., Granger D.M. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 88:1991;4651-4655.
8. Radomski M.W., Palmer R.M.J., Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide, and prostacyclin in platelets. Br J Pharmacol. 92:1987;181-187.
9. Stamler J.S., Mendelsohn M.E., Amarante P., Smick D., Andon N., Davies P.F., Cooke J.P., Loscalzo J. N-acetylcysteine potenciates platelet inhibition by endothelium-derived relaxing factor. Circ Res. 65:1989;789-795.
10. Radomski M.W., Palmer R.M.J., Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Natl Acad Sci USA. 87:1990;5193-5197.
11. Garg U.C., Hassid A. Nitric-oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 83:1989;1774-1777.
12. Palmer R.M.J., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
13. Palmer R.M.J., Rees D.D., Ashton D.S., Moncada S. L-arginine is the precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Common. 153:1988;1251-1256.
14. Cooke J.P., Singer A.H., Tsao P.S., Zera P., Rowan R.A., Billingham M.E. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 90:1992;1168-1172.
15. Tarry W.C., Makhoul R.G. L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty. Arterioscler Thromb. 14:1994;938-943.
16. Davies M.G., Kim J.H., Dalen H., Makhoul R.G., Svendsen E., Hagen P.O. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine. Surgery. 116:1994;557-568.
17. Ross R. The pathogenesis of atherosclerosis. N Engl J Med. 314:1986;488-500.
18. Komori K., Shimokawa H., Vanhoutte P.M. Hypercholesterolemia impairs endothelium-dependent relaxations to aggregating platelets in porcine iliac arteries. J Vasc Surg. 10:1989;318-325.
19. Campeau L., Enjalbert M., Lesperance J., Bourassa M.G., Kwiterovich P., Wacholder S., Sniderman A. The relation of risk factors to the development of atherosclerosis in saphenous vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med. 311:1984;1329-1332.
20. Itoh H., Komori K., Funahashi S., Okadome K., Sugimachi K. Intimal hyperplasia of experimental autologous vein graft in hyperlipidemic rabbits with poor distal runoff. Atherosclerosis. 110:1994;259-270.
21. Komori K., Gloviczki P., Bourchier R.G., Miller V.M., Vanhoutte P.M. Endothelium-dependent vasorelaxations in response to aggregating platelets are impaired in reversed vein graft. J Vasc Surg. 12:1990;139-147.
22. Komori K., Schini V.B., Gloviczki P., Bourchier R.G., Vanhoutte P.M. The impairment of endothelium dependent relaxations in reversed vein grafts is associated with a reduced production of cyclic GMP. J Vasc Surg. 14:1991;67-75.
23. Moore S., Stein H.W. Chromatography of amino acids on sulfonated polystyrene resions. J Biol Chem. 192:1951;663-681.
24. Yamaura S., Okadome K., Onohara T., Komori K., Sugimachi K. Blood flow and kinetics of smooth muscle cell proliferation in canine autologous vein grafts: In vivo bromodeoxyuridine incorporation. J Surg Res. 56:1994;155-161.
25. Eguchi D., Nishimura J., Kobayashi S., Komori K., Sugimachi K., Kanaide K. Mechanism of contraction induced by bradykinin in rabbit saphenous vein. Br J Pharmac. 120:1997;371-378.
26. Morinaga K., Eguchi H., Miyazaki T., Okadome K., Sugimachi K. Development and regression of intimal thickening of arterially transplanted autologous vein grafts in dogs. J Vasc Surg. 5:1987;719-730.
27. Cayatte A.J., Palacino J.J., Horten K., Coben R.A. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 14:1994;753-759.
28. Ishii T., Okadome K., Komori K., Odashiro T., Sugimachi K. Natural course of endothelium-dependent and -independent responses in autogenous femoral veins grafted into the arterial circulation of the dog. Circ Res. 72:1993;1004-1010.
29. Gajdusek C., DiCorleto P., Ross R., Schwartz S.M. An endothelial cell-derived growth factor. J Cell Biol. 85:1980;472-476.
30. Castellot J.J., Addonizio M.L., Rosenberg R.D., Karnovsky M.J. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J Cell Biol. 90:1981;372-379.
31. DiCorleto P.E., Bowen-Pope D.F. Cultured endothelial cells produce a platelet-derived growth factor-like protein. Proc Natl Acad Sci USA. 80:1983;1919-1923.
32. Castellot J.J., Faveau L.V., Karnovsky M.J., Rosenberg R.D. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. J Biol Chem. 257:1982;11256-11260.
33. Cole C.W., Hagen P.O., Lucas J.F., Mikat E.M., O'Malley M.K., Radic Z.S., Makhoul R.G., McCann R.L. Association of polymorphonuclear leukocytes with sites of aortic catheter-induced injury in rabbits. Atherosclerosis. 67:1987;229-236.
34. Cole C.W., Makhoul R.G., McCann R.L., O'Malley M.K., Hagen P.O. A neutrophil derived factor(s) stimulates [3H]-thymidine incorporation by vascular smooth muscle cells in vitro. Clin Invest Med. 11:1988;62-67.
35. Miller V.M., Reigel M.M., Hollier J.H., Vanhoutte P.M. Endothelium-dependent responses in autogenous femoral veins grafted into the arterial circulation. J Clin Invest. 80:1987;1350-1357.
36. Cross K.S., El-Sanadiki M.N., Murray J.J., Mikat E.M., McCann R.L., Hagen P.O. Functional abnormalities of experimental autogenous vein grafts neoendothelium. Ann Surg. 208:1988;631-638.
37. Komori K., Ishii T., Odashiro T., Itoh H., Mawatari K., Okadome K., Sugimachi K. Eicosapentanoic acid reduces the intimal thickening of autogenous vein grafts and enhances endothelium-derived relaxing factor. J Surg Res. 59:1995;747-753.
38. Komori K., Okadome K., Sugimachi K. Endothelium-derived relaxing factor and vein grafts. Br J Surg. 78:1991;1027-1030.
39. Frieman R.C., Mitchell G.G., Heistad D.D., Armstrong M.L., Harrison D.G. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primatres. Circ Res. 58:1986;783-789.
40. Komori K., Shimokawa H., Vanhoutte P.M. Hypercholesterolemia impairs endothelium-dependent relaxations to aggregating platelets in porcine iliac arteries. J Vasc Surg. 10:1989;318-325.
41. Ludmer P.L., Selwyn A.P., Shook T.L., Wayne R.R., Mudge G.H., Alexander R.W., Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Eng J Med. 315:1986;1046-1050.
42. Ross R, The pathogenesis of atherosclerosis: Aperspective for 1990s. Nature 1993;362:801-809.
43. Zwolak R.M., Adams M.C., Clowes A.W. Kinetics of vein graft hyperplasia: Association with tangenital stress. J Vasc Surg. 5:1987;126-136.
44. Scott-Burden T., Vanhoutte P.M. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation. 87(Suppl V):1993;51-57.